BLUE WATER ACQUISITION CORP.

Blue Water Acquisition Corp. Announces Stockholder Approval of Business Combination with Clarus Therapeutics, Inc.

Retrieved on: 
Friday, August 27, 2021
Business architecture, Register, XV, Accounting, Form, Acquisition, Tripura Merger Agreement, GLOBE, SEC, Business, Special, Nasdaq, Man, Risk, Division, Therapy, Forward-looking statement, 100,000, Securities Act of 1933, Bluewater, Special-purpose acquisition company, Prospectus, Failure, Solution, Corporate finance, Registration statement, Sale, Mergers and acquisitions, Woman, Security (finance)

Approximately 69.57% of the votes cast at the Special Meeting voted to approve the Business Combination.

Key Points: 
  • Approximately 69.57% of the votes cast at the Special Meeting voted to approve the Business Combination.
  • In light of receipt of the requisite approvals by Blue Waters stockholders described above, Blue Water expects the Business Combination to be completed promptly following the satisfaction or waiver of the other conditions to the consummation of the Business Combination, as applicable.
  • About Blue Water Acquisition Corp.
    Blue Water is a special purpose acquisition company formed in Delaware for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • Neither of Blue Water and Clarus gives any assurance that Blue Water, Clarus, or the combined company, will achieve its expectations.

Blue Water Acquisition Corp. Announces Change of Special Meeting of Shareholders Date to August 27, 2021

Retrieved on: 
Wednesday, August 11, 2021
Transfer, Acquisition, Special, Division, Risk, NASDAQ, Register, Sale, SEC, Agreement, Therapy, Registration statement, Bluewater, Exercise, SPAC, Form, Name, Business architecture, Man, Blue Water Bridge Authority, Plan, Business, Prospectus, Corporate finance, Accounting, Company, GLOBE, Eastern Time Zone, Failure, 100,000, Security (finance), Tripura Merger Agreement, XV, Xi, Special-purpose acquisition company, Forward-looking statement, Securities Act of 1933, Woman

The Company plans to continue to solicit proxies from stockholders during the period prior to the Special Meeting.

Key Points: 
  • The Company plans to continue to solicit proxies from stockholders during the period prior to the Special Meeting.
  • Only the holders of Blue Waters common stock as of the close of business on July 16, 2021, the record date for the Special Meeting, are entitled to vote at the Special Meeting.
  • About Blue Water Acquisition Corp.
    Blue Water is a special purpose acquisition company formed in Delaware for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • Neither of Blue Water and Clarus gives any assurance that Blue Water, Clarus, or the combined company, will achieve its expectations.

Clarus Therapeutics And HavaH Therapeutics Announce Licensing Agreement For Product To Treat Androgen-Dependent Inflammatory Breast Disease And Certain Forms Of Breast Cancer

Retrieved on: 
Tuesday, May 25, 2021

If approved, CLAR-121 would be the first T treatment of its kind for inflammatory breast disease.

Key Points: 
  • If approved, CLAR-121 would be the first T treatment of its kind for inflammatory breast disease.
  • If approved, CLAR-121 would be the first T treatment of its kind for inflammatory breast disease, including inflammatory periductal mastitis (PDM) and estrogen receptor-positive (ER+) breast cancer.
  • Under the terms of the licensing agreement, Clarus will be responsible for future global development and regulatory activities for CLAR-121, excluding Australia.
  • Reedland Capital Partners, acting through Weild & Co., member FINRA/SIPC, served as financial advisor to HavaH in connection with this transaction.

Blue Water Acquisition Corp. Receives Expected Notice from Nasdaq Regarding Delayed Annual Report

Retrieved on: 
Thursday, April 22, 2021

The Staff Statement, among other things, highlighted the potential accounting implications of certain terms that are common in warrants issued in connection with the initial public offerings of special purpose acquisition companies (\xe2\x80\x9cSPAC\xe2\x80\x9d) such as the Company.

Key Points: 
  • The Staff Statement, among other things, highlighted the potential accounting implications of certain terms that are common in warrants issued in connection with the initial public offerings of special purpose acquisition companies (\xe2\x80\x9cSPAC\xe2\x80\x9d) such as the Company.
  • Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company\xe2\x80\x99s management.
  • All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.\n"

Blue Water Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing February 9, 2021

Retrieved on: 
Monday, February 8, 2021
Finance, Financial markets, Economy, Corporate finance, Private equity, Special-purpose acquisition company, NASDAQ, Stock exchange, NASDAQ, Stock market

ClassA Common Stock and warrants that are separated will trade on the Nasdaq Capital Market (Nasdaq) under the symbols BLUW and BLUWW, respectively.

Key Points: 
  • ClassA Common Stock and warrants that are separated will trade on the Nasdaq Capital Market (Nasdaq) under the symbols BLUW and BLUWW, respectively.
  • Those units not separated will continue to trade on Nasdaq under the symbol BLUWU.
  • About Blue Water Acquisition Corp.
    Blue Water Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.